Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "warming"

17 News Found

Honeywell, Recipharm to speed development of inhalers
News | August 18, 2023

Honeywell, Recipharm to speed development of inhalers

Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs

AstraZeneca announces US$400 million investment in reforestation and biodiversity
News | June 28, 2023

AstraZeneca announces US$400 million investment in reforestation and biodiversity

New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia

NAFLD clinical trial activity catching up in China but lacks substantial domestic participation, says GlobalData
News | December 27, 2022

NAFLD clinical trial activity catching up in China but lacks substantial domestic participation, says GlobalData

China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.

M2 milk platform to develop cell-cultured milk
Healthcare | March 22, 2022

M2 milk platform to develop cell-cultured milk

Building the future of food in the birthplace of cell-cultured milk

AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers
Sustainability | February 22, 2022

AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers

New inhalers would have near-zero Global Warming Potential propellant

AstraZeneca India launches solar project to achieve sustainability goals
Sustainability | October 11, 2021

AstraZeneca India launches solar project to achieve sustainability goals

The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality

Agilent Technologies Foundation partners with five hospitals for Covid-19 research
Digitisation | August 19, 2021

Agilent Technologies Foundation partners with five hospitals for Covid-19 research

Agilent Technologies Inc. announced the contribution of Agilent AriaMx Real-Time qPCR instruments to five research hospitals in India to support their COVID-19 initiatives and help them serve the community at large

Latest Stories

BioMed X launches AI-driven bispecific antibody research team in France

Freudenberg Medical launches ISO Class 5 cleanroom, 'CleanAssure'

India Autism Center highlights inclusive residential care at ALFOC Conclave 2026

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging